Cervical Cancer
Conditions
Keywords
Locally advanced cervical cancer, more than IB3 stage FIGO 2018, Para aortic lymphadenectomy, Laparoscopy, PET/CT
Brief summary
Cervical cancer affects more than 3000 new cases per year in France. The treatment of stage IB3 to IVA cervical cancer is based on concomitant radio-chemotherapy. The irradiation volumes are based, according to current recommendations, on imaging examinations and / or on the results of a laparoscopic Para-aortic lymphadenectomy (PAL). There is some risk of false negatif with the PET/CT. For this reason, most of the time, PAL is offered when there is no pathological paraaortic lymph node on PET/CT. The investigators suppose that this staging surgery could be avoid when no pathological pelvic nodes are identified on PET/CT. The investigators use a retrospective study, to analyse histological report of systematic PAL, comparing to results of pre-operative PET/CT.
Interventions
Para Aortic Lymphadenectomy (PAL) by laparoscopy
Sponsors
Study design
Eligibility
Inclusion criteria
\- Patients with : * locally advanced cervical cancer, * who undergone PAL * with pre operative PET CT, between January 2015 and december 2019
Exclusion criteria
\- patients aged under 18
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| negative predictive value of PET/CT on para aortic nodes when no pathological pelvic nodes. | 1 day | negative predictive value of PET/CT on para aortic nodes when no pathological pelvic nodes. The intraoperative 3D optical scan gives the tumor localization obtained by radioguided occult lesion localization thanks to pen marking left by the surgeon. The comparison is done by superimposing both acquisitions. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| morbidity of PAL | 1 day | morbidity of PAL |
Countries
France